Histogenics

HSGX:NAS

Biotechnology

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2021

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Biotechnology Founded 2000

Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

website

Headquarters

3rd floor

830 Winter Street

Waltham, MA 02451

1.781.547.7900

Executives

Name	Title	Gender
Jonathan I. Lieber, MBA	Chief Financial Officer	Male
Garheng Kong, MD, PhD	Chairman	Male
Adam D. Gridley, MBA	President, CEO & Director	Male
Peter Hamilton, MBA	Vice President-Operations & Engineering	Male
Stephen R. Kennedy, MBA	Chief Technology Officer	Male
Gloria Matthews, PhD, DVM	Chief Medical Officer	Female

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

2 N/A

Histogenics - Competitors and Related Companies

How Histogenics stacks up to its peers in the Biotechnology industry or with competing business segments.